Skip to main content
TipRanks
Go Ultimate75% OFF

Scott Canute Insider Profile

4 Followers

Scott Canute, Director at Akebia Therapeutics, holds 0.00 shares in Flexion Therapeutics (Ticker: ~FLXN), holds 0.00 shares in Immunomedics (Ticker: IMMU), holds 13.70K shares in Akebia Therapeutics (Ticker: AKBA).

Scott Canute's Trading History

~FLXN
Flexion Therapeutics
Nov 19, 2021―Uninformative Sell76.50K$0.00
IMMU
Immunomedics
Oct 23, 2020―Uninformative Sell―$0.00
AKBA
Akebia Therapeutics
Jun 10, 2019DirectorUninformative Buy―$5.49K
ONSIU
Oncobiologics Inc
Nov 30, 2016―Uninformative Buy―$891.77K
OTLK
Outlook Therapeutics
Nov 14, 2016DirectorUninformative Buy234.78K―
LLY
Eli Lilly & Co
―President, Mfg. Operations―$66.89M
TARA
Protara Therapeutics
―Director―$0.00
ONCR
Oncorus
――――

You May Also Like

Scott Canute insider profile FAQ

What stocks does Scott Canute hold?
Scott Canute holds: AKBA, IMMU, ~FLXN, ONSIU, OTLK, ONCR, TARA, LLY stocks.
What was Scott Canute’s latest transaction?
Scott Canute’s latest transaction was an Uninformative Sell of $76.50K.
What is Scott Canute's role in Akebia Therapeutics?
Scott Canute's role in Akebia Therapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.

TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.